Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dyne Therapeutics Inc.

    NASDAQ: DYN · Real-Time Price · USD
    13.81
    -0.60 (-4.16%)
    At close: Jun 16, 2025, 3:59 PM
    14.00
    1.41%
    Pre-market: Jun 17, 2025, 07:15 AM EDT

    Dyne Therapeutics Statistics

    Share Statistics

    Dyne Therapeutics has 113.67M shares outstanding. The number of shares has increased by 15.57% in one year.

    Shares Outstanding

    n/a
    		 113.67M

    Shares Change (YoY)

    n/a
    		 15.57%

    Shares Change (QoQ)

    n/a
    		 11.16%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 85.23M

    Failed to Deliver (FTD) Shares

    n/a
    		 74

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 25.53M, so 22.46% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 25.53M

    Short % of Shares Out

    n/a
    		 22.46%

    Short % of Float

    n/a
    		 25.83%

    Short Ratio (days to cover)

    n/a
    		 18

    Valuation Ratios

    The PE ratio is -6.99 and the forward PE ratio is -3.83. Dyne Therapeutics's PEG ratio is 0.48.

    PE Ratio

    n/a
    		 -6.99

    Forward PE

    n/a
    		 -3.83

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.1

    PB Ratio

    n/a
    		 3.52

    P/FCF Ratio

    n/a
    		 -7.53

    PEG Ratio

    n/a
    		 0.48
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Dyne Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.6, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 15.6

    Quick Ratio

    n/a
    		 15.6

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.08

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,653,218.75

    Employee Count

    n/a
    		 192

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -56.56% in the last 52 weeks. The beta is 1.16, so Dyne Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.16

    52-Week Price Change

    n/a
    		 -56.56%

    50-Day Moving Average

    n/a
    		 11.23

    200-Day Moving Average

    n/a
    		 20.79

    Relative Strength Index (RSI)

    n/a
    		 58.81

    Average Volume (20 Days)

    n/a
    		 2,523,606

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -343.89M

    Net Income

    n/a
    		 -317.42M

    EBITDA

    n/a
    		 -315.18M

    EBIT

    n/a
    		 -317.42M

    Earnings Per Share (EPS)

    n/a
    		 -3.37
    Full Income Statement

    Balance Sheet

    The company has 435.45M in cash and 23.99M in debt, giving a net cash position of 411.46M.

    Cash & Cash Equivalents

    n/a
    		 435.45M

    Total Debt

    n/a
    		 23.99M

    Net Cash

    n/a
    		 411.46M

    Retained Earnings

    n/a
    		 -949.93M

    Total Assets

    n/a
    		 721.07M

    Working Capital

    n/a
    		 655.62M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -292.37M and capital expenditures -2.38M, giving a free cash flow of -294.75M.

    Operating Cash Flow

    n/a
    		 -292.37M

    Capital Expenditures

    n/a
    		 -2.38M

    Free Cash Flow

    n/a
    		 -294.75M

    FCF Per Share

    n/a
    		 -3.13
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DYN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DYN is $48, which is 247.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $48

    Price Target Difference

    n/a
    		 247.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 13
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 12.6

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist